Sunpeaks Ventures Signs Marketing and Sponsorship Agreement with Major University Sports Program
SILVER SPRING, Md., May 8, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that Sunpeaks has entered into a marketing and sponsorship agreement (the "Agreement") with a Division I-A college sports program.
The terms of the marketing and sponsorship program provide that the university will feature Clotamin on field level signage during regular season home football games. The marketing agreement also provides that the university will feature Clotamin in a full-page 4-color advertisement in the University football program. The Agreement also calls for Clotamin to receive online website exposure on the official website and a full-page advertisement in six issues of the sports E-Magazine. Sunpeaks has tendered payment under the Agreement.
"We have already been effective at establishing a distribution network in target markets and with select successful sports programs, and Clotamin is now available at locations in the target regions. This agreement is meant to leverage that success with local and national popularity of select well-known professional and college sports programs," stated Mackie A. Barch, CEO of Sunpeaks Ventures.
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or email@example.com
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.
More by this Source
Sunpeaks Ventures Announces Name Change to Pharmagen, Inc.
Jan 14, 2013, 09:24 ET
Sunpeaks Ventures Announces Hiring of Chief Financial Officer
Dec 27, 2012, 13:58 ET
Sunpeaks Ventures Closes $7.5MM Committed Equity Facility with TCA Global Credit Master Fund
Dec 17, 2012, 17:20 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.